Aveanna Healthcare Holdings, Inc. current report, 16 May 2024

Business Context and Reporting Period

Aveanna Healthcare Holdings Inc. filed this Form 8-K to report the final voting results from its 2024 Annual Meeting of Stockholders held on May 16, 2024. The filing was signed on May 17, 2024. No operating or financial-period results were reported.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.

Material Changes

  • Three Class III director nominees were elected to three-year terms ending at the 2027 Annual Meeting or until successors are elected and qualified.
  • Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 28, 2024.
  • The stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers.

Voting Results

ProposalForAgainstWithheld/AbstentionsBroker Non-Votes
Election of Sheldon M. Retchin164,264,106—5,300,876 withheld8,365,028
Election of Erica G. Schwartz168,460,462—1,104,520 withheld8,365,028
Election of Jeff Shaner163,330,989—6,230,969 withheld8,368,052
Ratification of Ernst & Young LLP177,333,03194,541502,438 abstentions0
Advisory executive compensation approval169,424,014119,09121,953 abstentions8,364,952

Guidance, Outlook, Risks, and Unusual Items

The filing provides no financial guidance, outlook, management commentary, risk updates, contingencies, or unusual items. No other matters were considered or voted upon at the meeting.

Investor Verification Items

  • Confirm the election and three-year terms of the three Class III directors.
  • Confirm Ernst & Young LLP’s appointment for the fiscal year ending December 28, 2024.
  • Review the Company’s proxy statement for detailed executive compensation disclosures and the advisory vote context.
  • Consult the Company’s periodic financial filings for operating performance, liquidity, debt, and outlook information, which are not included in this Form 8-K.